1. Home
  2. LUNR vs IMNM Comparison

LUNR vs IMNM Comparison

Compare LUNR & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intuitive Machines Inc.

LUNR

Intuitive Machines Inc.

HOLD

Current Price

$17.82

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$21.66

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LUNR
IMNM
Founded
2013
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LUNR
IMNM
Price
$17.82
$21.66
Analyst Decision
Buy
Strong Buy
Analyst Count
10
10
Target Price
$18.00
$32.10
AVG Volume (30 Days)
8.2M
989.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.06
EPS
N/A
N/A
Revenue
N/A
$9,041,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$228.97
$11.53
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.14
$5.15
52 Week High
$23.32
$27.65

Technical Indicators

Market Signals
Indicator
LUNR
IMNM
Relative Strength Index (RSI) 50.63 42.59
Support Level $17.16 $18.98
Resistance Level $19.68 $22.57
Average True Range (ATR) 1.65 1.18
MACD -0.03 -0.20
Stochastic Oscillator 68.75 9.23

Price Performance

Historical Comparison
LUNR
IMNM

About LUNR Intuitive Machines Inc.

Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure. The Company operates in one operating segment and one reportable segment underpinned by three core pillars (delivery services, data transmission services, and infrastructure as a service) that have similar capabilities, customers, and economic characteristics. Revenue is from contracts with customers of orbital and lunar access services.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: